ASH 2021 – Focused on GVHD for Pharmacists

The 2021 American Society of Hematology Annual Meeting (ASH) is taking place December 11-14, virtually and in-person in Atlanta, Georgia. This year’s program provides attendees with insights into the latest advances in hematology, including research highlighting the transformative role immunotherapies are playing in the treatment of major blood cancers. This page series will provide coverage of the highlights in GVHD for pharmacists being presented at the meeting.

Look out for coverage of the meeting and click here to learn more about the 2021 ASH Annual Meeting.

Evaluating Mosunetuzumab and Polatuzumab Vedotin in Relapsed/Refractory B-Cell NHL

Mosunetuzumab was safe and efficacious for patients with heavily pretreated relapsed and/or refractory B-cell non-Hodgkin lymphoma (NHL) when combined...

Study Reviews Response and Survival Outcomes of Transplant for Waldenström Macroglobulinemia

A study that reviewed response and survival outcomes in Waldenström macroglobulinemia (WM) patients who underwent autologous stem cell transplantation...

GRIFFIN: Long-Term Follow-up Shows Durability of Daratumumab Responses in Transplant-Eligible Myeloma

According to extended follow-up from the GRIFFIN trial, the combination of daratumumab and lenalidomide, bortezomib, and dexamethasone (D-RVd) continued...

Promising Results With Magrolimab Added to Azacitidine With Venetoclax in Newly Diagnosed, High-Risk Acute...

The treatment combination of azacitidine with venetoclax and magrolimab was safe and highly effective in older and high-risk patients...

CAR T-Cell Therapy Tisa-Cel Noninferior to Standard of Care in Relapsed/Refractory Aggressive B-Cell NHL

Patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (NHL) who received second-line treatment with the autologous CD19-targeting chimeric antigen receptor...

Better Access to Transfusion Services Could Improve Hospice Enrollment

Patients with hematologic malignancies who may require blood transfusions may not be able to enroll in hospice care given...

Curated Journal Abstracts

Advertisement
Advertisement